El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

587827.pdf (294.38 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2010-01-15

Llicència de publicació

cc-by (c) Haq,I. et al., 2010
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/55211

Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1186/1471-2350-11-7

Resum

BACKGROUND: Genetic factors play a role in chronic obstructive pulmonary disease (COPD) but are poorly understood. A number of candidate genes have been proposed on the basis of the pathogenesis of COPD. These include the matrix metalloproteinase (MMP) genes which play a role in tissue remodelling and fit in with the protease--antiprotease imbalance theory for the cause of COPD. Previous genetic studies of MMPs in COPD have had inadequate coverage of the genes, and have reported conflicting associations of both single nucleotide polymorphisms (SNPs) and SNP haplotypes, plausibly due to under-powered studies. METHODS: To address these issues we genotyped 26 SNPs, providing comprehensive coverage of reported SNP variation, in MMPs- 1, 9 and 12 from 977 COPD patients and 876 non-diseased smokers of European descent and evaluated their association with disease singly and in haplotype combinations. We used logistic regression to adjust for age, gender, centre and smoking history. RESULTS: Haplotypes of two SNPs in MMP-12 (rs652438 and rs2276109), showed an association with severe/very severe disease, corresponding to GOLD Stages III and IV. CONCLUSIONS: Those with the common A-A haplotype for these two SNPs were at greater risk of developing severe/very severe disease (p = 0.0039) while possession of the minor G variants at either SNP locus had a protective effect (adjusted odds ratio of 0.76; 95% CI 0.61 - 0.94). The A-A haplotype was also associated with significantly lower predicted FEV1 (42.62% versus 44.79%; p = 0.0129). This implicates haplotypes of MMP-12 as modifiers of disease severity.

Matèries

Malalties pulmonars obstructives cròniques, Genètica molecular, Genètica mèdica

Matèries (anglès)

Chronic obstructive pulmonary diseases, Molecular genetics, Medical genetics

Citació

Col·leccions

Articles publicats en revistes (Medicina)

Citació

HAQ, Imran, CHAPPELL, Sally, JOHNSON, Simon r., LOTYA, Juzer, DALY, Leslie, MORGAN, Kevin, GUETTA-BARANES, Tamar, ROCA TORRENT, Josep, RABINOVICH, Roberto alejandro, MILLAR, Anna b., DONNELLY, Seamas c., KEATINGS, Vera, MACNEE, William, STOLK, Jan, HIEMSTRA, Pieter s., MINIATI, Massimo, MONTI, Simonetta, O'CONNOR, Clare m., KALSHEKER, Noor. Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.. _BMC Medical Genomics_. 2010. Vol. 15, núm. 11, pàgs. 7. [consulta: 31 de desembre de 2025]. ISSN: 1755-8794. [Disponible a: https://hdl.handle.net/2445/55211]

Exportar metadades

JSON - METS

Compartir registre